← FDA DRUG APPROVALS

FDA ANDA · ANDA065350

CEFACLOR

Sponsor: HIKMA

APPLICATION
ANDA065350
TYPE
ANDA
ORIGINAL APPROVAL
2007-04-03
LATEST ACTION
2015-07-14
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Discontinued

Products

CEFACLORDiscontinued
CEFACLOR EQ 250MG BASE · CAPSULE · ORAL
CEFACLORDiscontinued
CEFACLOR EQ 500MG BASE · CAPSULE · ORAL

Approval history

2015-07-14Labeling · Supplement 6 · standardAP
2007-04-03OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →